Global Cancer Stem Cell Market Size, Status and Forecast 2019-2025

Published On: Jun 2019

Format: PDF

Publisher: QY Research

Pages: 90

Report ID: 1473

Cancer stem cells (CSCs) refer to the cells obtained from tumor that posses potential to reproduce all types of cancer cells found in a cancer sample. Cancer stem cells are planned to grow in tumors as a separate population and thereby cause deterioration and metastasis of existing tumor through generation of new tumor. Thus, with advancement in technology especially in cancer stem cells research area, therapies specific to targeting cancer stem cells are expected to improve quality of life and survival cases of cancer patients with metastatic diseases.
North America was the leading revenue contributor of the cancer stem cells market in 2016 due to presence of a substantial number of organizations engaged in conducting R&D activities related to stem cell therapy. There are several internationally recognized hospitals and medical institutes, such as Cancer Treatment Centers of America at Midwestern Regional Medical Center, which offer stem cell transplant therapies.
Asia Pacific is expected to be a promising region in the arena owing to presence of several organizations in the region that focus on R&D of stem cells. Moreover, funding agencies are providing grants to research communities to accelerate their scientific research on cancer stem cells in Asian countries.
In 2018, the global Cancer Stem Cell market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Cancer Stem Cell status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cancer Stem Cell development in United States, Europe and China.

The key players covered in this study
Thermo Fisher Scientific, Inc.
AbbVie, Inc.
Merck KGaA
Bionomics
Lonza
Stemline Therapeutics, Inc.
Miltenyi Biotec
PromoCell GmbH
MacroGenics, Inc.
OncoMed Pharmaceuticals, Inc.
Irvine Scientific
STEMCELL Technologies Inc.
Sino Biological Inc.
BIOTIME, Inc.

Market segment by Type, the product can be split into
Cell Culturing
Cell Separation
Cell Analysis
Molecular Analysis
Others

Market segment by Application, split into
Stem Cell Based Cancer Therapy
Targeted CSCs

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Cancer Stem Cell status, future forecast, growth opportunity, key market and key players.
To present the Cancer Stem Cell development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Cancer Stem Cell are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Cancer Stem Cell Market Size Growth Rate by Type (2014-2025)
1.4.2 Cell Culturing
1.4.3 Cell Separation
1.4.4 Cell Analysis
1.4.5 Molecular Analysis
1.4.6 Others
1.5 Market by Application
1.5.1 Global Cancer Stem Cell Market Share by Application (2014-2025)
1.5.2 Stem Cell Based Cancer Therapy
1.5.3 Targeted CSCs
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Cancer Stem Cell Market Size
2.2 Cancer Stem Cell Growth Trends by Regions
2.2.1 Cancer Stem Cell Market Size by Regions (2014-2025)
2.2.2 Cancer Stem Cell Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Cancer Stem Cell Market Size by Manufacturers
3.1.1 Global Cancer Stem Cell Revenue by Manufacturers (2014-2019)
3.1.2 Global Cancer Stem Cell Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Cancer Stem Cell Market Concentration Ratio (CR5 and HHI)
3.2 Cancer Stem Cell Key Players Head office and Area Served
3.3 Key Players Cancer Stem Cell Product/Solution/Service
3.4 Date of Enter into Cancer Stem Cell Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Cancer Stem Cell Market Size by Type (2014-2019)
4.2 Global Cancer Stem Cell Market Size by Application (2014-2019)

5 United States
5.1 United States Cancer Stem Cell Market Size (2014-2019)
5.2 Cancer Stem Cell Key Players in United States
5.3 United States Cancer Stem Cell Market Size by Type
5.4 United States Cancer Stem Cell Market Size by Application

6 Europe
6.1 Europe Cancer Stem Cell Market Size (2014-2019)
6.2 Cancer Stem Cell Key Players in Europe
6.3 Europe Cancer Stem Cell Market Size by Type
6.4 Europe Cancer Stem Cell Market Size by Application

7 China
7.1 China Cancer Stem Cell Market Size (2014-2019)
7.2 Cancer Stem Cell Key Players in China
7.3 China Cancer Stem Cell Market Size by Type
7.4 China Cancer Stem Cell Market Size by Application

8 Japan
8.1 Japan Cancer Stem Cell Market Size (2014-2019)
8.2 Cancer Stem Cell Key Players in Japan
8.3 Japan Cancer Stem Cell Market Size by Type
8.4 Japan Cancer Stem Cell Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Cancer Stem Cell Market Size (2014-2019)
9.2 Cancer Stem Cell Key Players in Southeast Asia
9.3 Southeast Asia Cancer Stem Cell Market Size by Type
9.4 Southeast Asia Cancer Stem Cell Market Size by Application

10 India
10.1 India Cancer Stem Cell Market Size (2014-2019)
10.2 Cancer Stem Cell Key Players in India
10.3 India Cancer Stem Cell Market Size by Type
10.4 India Cancer Stem Cell Market Size by Application

11 Central & South America
11.1 Central & South America Cancer Stem Cell Market Size (2014-2019)
11.2 Cancer Stem Cell Key Players in Central & South America
11.3 Central & South America Cancer Stem Cell Market Size by Type
11.4 Central & South America Cancer Stem Cell Market Size by Application

12 International Players Profiles
12.1 Thermo Fisher Scientific, Inc.
12.1.1 Thermo Fisher Scientific, Inc. Company Details
12.1.2 Company Description and Business Overview
12.1.3 Cancer Stem Cell Introduction
12.1.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Stem Cell Business (2014-2019)
12.1.5 Thermo Fisher Scientific, Inc. Recent Development
12.2 AbbVie, Inc.
12.2.1 AbbVie, Inc. Company Details
12.2.2 Company Description and Business Overview
12.2.3 Cancer Stem Cell Introduction
12.2.4 AbbVie, Inc. Revenue in Cancer Stem Cell Business (2014-2019)
12.2.5 AbbVie, Inc. Recent Development
12.3 Merck KGaA
12.3.1 Merck KGaA Company Details
12.3.2 Company Description and Business Overview
12.3.3 Cancer Stem Cell Introduction
12.3.4 Merck KGaA Revenue in Cancer Stem Cell Business (2014-2019)
12.3.5 Merck KGaA Recent Development
12.4 Bionomics
12.4.1 Bionomics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Cancer Stem Cell Introduction
12.4.4 Bionomics Revenue in Cancer Stem Cell Business (2014-2019)
12.4.5 Bionomics Recent Development
12.5 Lonza
12.5.1 Lonza Company Details
12.5.2 Company Description and Business Overview
12.5.3 Cancer Stem Cell Introduction
12.5.4 Lonza Revenue in Cancer Stem Cell Business (2014-2019)
12.5.5 Lonza Recent Development
12.6 Stemline Therapeutics, Inc.
12.6.1 Stemline Therapeutics, Inc. Company Details
12.6.2 Company Description and Business Overview
12.6.3 Cancer Stem Cell Introduction
12.6.4 Stemline Therapeutics, Inc. Revenue in Cancer Stem Cell Business (2014-2019)
12.6.5 Stemline Therapeutics, Inc. Recent Development
12.7 Miltenyi Biotec
12.7.1 Miltenyi Biotec Company Details
12.7.2 Company Description and Business Overview
12.7.3 Cancer Stem Cell Introduction
12.7.4 Miltenyi Biotec Revenue in Cancer Stem Cell Business (2014-2019)
12.7.5 Miltenyi Biotec Recent Development
12.8 PromoCell GmbH
12.8.1 PromoCell GmbH Company Details
12.8.2 Company Description and Business Overview
12.8.3 Cancer Stem Cell Introduction
12.8.4 PromoCell GmbH Revenue in Cancer Stem Cell Business (2014-2019)
12.8.5 PromoCell GmbH Recent Development
12.9 MacroGenics, Inc.
12.9.1 MacroGenics, Inc. Company Details
12.9.2 Company Description and Business Overview
12.9.3 Cancer Stem Cell Introduction
12.9.4 MacroGenics, Inc. Revenue in Cancer Stem Cell Business (2014-2019)
12.9.5 MacroGenics, Inc. Recent Development
12.10 OncoMed Pharmaceuticals, Inc.
12.10.1 OncoMed Pharmaceuticals, Inc. Company Details
12.10.2 Company Description and Business Overview
12.10.3 Cancer Stem Cell Introduction
12.10.4 OncoMed Pharmaceuticals, Inc. Revenue in Cancer Stem Cell Business (2014-2019)
12.10.5 OncoMed Pharmaceuticals, Inc. Recent Development
12.11 Irvine Scientific
12.12 STEMCELL Technologies Inc.
12.13 Sino Biological Inc.
12.14 BIOTIME, Inc.

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details